Medicine & Research - 2004
| 19.03.2004 | Fresenius receives Orphan Drug Designation for antibody removab® to treat patients with ovarian cancer |
Text as PDF-file
|
Fresenius SE & Co. KGaA
- Who we are
- Investor Relations
- Press
- Health Care
- Career
